157 related articles for article (PubMed ID: 17021890)
1. Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients?
Neubert A; Dormann H; Weiss J; Criegee-Rieck M; Ackermann A; Levy M; Brune K; Rascher W
Eur J Clin Pharmacol; 2006 Nov; 62(11):959-65. PubMed ID: 17021890
[TBL] [Abstract][Full Text] [Related]
2. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values.
Haffner S; von Laue N; Wirth S; Thürmann PA
Drug Saf; 2005; 28(5):453-64. PubMed ID: 15853446
[TBL] [Abstract][Full Text] [Related]
3. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients.
Neubert A; Dormann H; Weiss J; Egger T; Criegee-Rieck M; Rascher W; Brune K; Hinz B
Drug Saf; 2004; 27(13):1059-67. PubMed ID: 15471510
[TBL] [Abstract][Full Text] [Related]
4. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection.
Weiss J; Krebs S; Hoffmann C; Werner U; Neubert A; Brune K; Rascher W
Pediatrics; 2002 Aug; 110(2 Pt 1):254-7. PubMed ID: 12165575
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Reporting Adverse Drug Reactions in Paediatric Patients in a University Hospital in the Netherlands.
Dittrich ATM; Draaisma JMT; van Puijenbroek EP; Loo DMWMT
Paediatr Drugs; 2020 Aug; 22(4):425-432. PubMed ID: 32557243
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive intervention for adverse drug reactions identification and reporting in a Pediatric Emergency Department.
Morales Ríos O; Jasso Gutiérrez L; Talavera JO; Téllez-Rojo MM; Olivar López V; Garduño Espinosa J; Muñoz Hernández O
Int J Clin Pharm; 2016 Feb; 38(1):80-7. PubMed ID: 26499501
[TBL] [Abstract][Full Text] [Related]
7. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
[TBL] [Abstract][Full Text] [Related]
8. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database.
Egger T; Dormann H; Ahne G; Runge U; Neubert A; Criegee-Rieck M; Gassmann KG; Brune K
Drugs Aging; 2003; 20(10):769-76. PubMed ID: 12875612
[TBL] [Abstract][Full Text] [Related]
9. Computerized survelliance of adverse drug reactions in hospital: pilot study.
Azaz-Livshits T; Levy M; Sadan B; Shalit M; Geisslinger G; Brune K
Br J Clin Pharmacol; 1998 Mar; 45(3):309-14. PubMed ID: 10896407
[TBL] [Abstract][Full Text] [Related]
10. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
12. [Knowledge creation about adverse drug reactions in the paediatric population].
Aagaard L
Ugeskr Laeger; 2013 Feb; 175(6):342-5. PubMed ID: 23402239
[TBL] [Abstract][Full Text] [Related]
13. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Severe Adverse Drug Reactions at a Free-Standing Children's Hospital.
Yu D; Sheets J; Suppes S; Goldman J
J Clin Pharmacol; 2019 Dec; 59(12):1569-1572. PubMed ID: 31309572
[TBL] [Abstract][Full Text] [Related]
15. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India.
Tandon VR; Mahajan V; Khajuria V; Gillani Z
Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314
[TBL] [Abstract][Full Text] [Related]
16. Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology.
Dormann H; Criegee-Rieck M; Neubert A; Egger T; Levy M; Hahn EG; Brune K
Aliment Pharmacol Ther; 2004 Feb; 19(3):303-9. PubMed ID: 14984377
[TBL] [Abstract][Full Text] [Related]
17. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
18. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
19. [Understanding and reducing the risk of adverse drug reactions in pediatric patients].
Gotta V; van den Anker J; Pfister M
Ther Umsch; 2015 Dec; 72(11-12):679-86. PubMed ID: 26654811
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions in Ghanaian children: review of reports from 2000 to 2012 in VigiBase.
Cliff-Eribo KO; Choonara I; Dodoo A; Darko DM; Sammons H
Expert Opin Drug Saf; 2015; 14(12):1827-33. PubMed ID: 26436964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
